Anti-ICAM1 [BU74]
Invented at University Of Birmingham
- Datasheet
- References (2)
- Inventor Info
Info
| Catalogue Number | 151490 |
| Applications | FACS IHC IP |
| Antigen/Gene or Protein Targets | ICAM1 (CD54) |
| Synonyms | Intercellular Adhesion Molecule 1; Major Group Rhinovirus Receptor; ICAM-1; Cell Surface Glycoprotein P3.58; Human Rhinovirus Receptor; P3.58; CD54; BB2 |
| Reactivity | Human |
| Relevance | ICAMs are members of the immunoglobulin superfamily that is characterised by the presence of immunoglobulin-like domains. ICAM-1 is expressed in haemopoietic cells and vascular endothelium. Cytokine activation causes ICAM-1 expression in other cell types such as fibroblasts and keratinocytes. ICAM-1 is involved in leukocyte recruitment and inflammation. ICAM-1 binds LFA-1 (CD11a/CD18) and Mac-1 (CD11b/CD18). |
| Host | Mouse |
| Subclass | IgM |
| Myeloma Used | P3/NS1/1-Ag4.1 |
| Recommended Growing Conditions | RPMI 1640 + 10% FCS |
| Strain | Balb/c |
| Notes | Flow Cytometry: 1/25 to 1/100 |
| Research Area | Adhesion, Cardiovascular, Immunology, Stem Cell Biology |
References: 2 entries
Baker et al. 1998. Blood. 92(8):2830-43. PMID: 9763568.
Prolonged phenotypic, functional, and molecular change in group I Burkitt lymphoma cells on short-term exposure to CD40 ligand.
Europe PMC ID: 9763568
Add a reference
References: 2 entries
Baker et al. 1998. Blood. 92(8):2830-43. PMID: 9763568.
Prolonged phenotypic, functional, and molecular change in group I Burkitt lymphoma cells on short-term exposure to CD40 ligand.
Add a reference
